Literature DB >> 4563024

Increased plasma enzyme concentrations in rats with functional ischaemia of muscle provide a possible model of Duchenne muscular dystrophy.

J R Mendell, W K Engel, E C Derrer.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4563024     DOI: 10.1038/239522a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  11 in total

1.  Exercise and neuromuscular disease.

Authors:  B T Adornato
Journal:  West J Med       Date:  1979-10

Review 2.  Hypotheses and recent findings concerning aetiology and pathogenesis of the muscular dystrophies.

Authors:  F Jerusalem
Journal:  J Neurol       Date:  1976       Impact factor: 4.849

3.  Attenuation of soman-induced lesions of skeletal muscle by acetylcholinesterase reactivating and non-reactivating antidotes.

Authors:  A Dekleva; D Sket; J Sketelj; M Brzin
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

4.  Nerve, muscle, and serotonin.

Authors:  M Takamori
Journal:  J Neurol Neurosurg Psychiatry       Date:  1977-01       Impact factor: 10.154

5.  Experimental serotonin myopathy as an animal model of muscle degeneration and regeneration in muscular dystrophy.

Authors:  H Narukami; K Yoshioka; J Zhao; T Miike
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

6.  Carcinoid myopathy and treatment with cyproheptadine (Periactin).

Authors:  E M Berry; C Maunder; M Wilson
Journal:  Gut       Date:  1974-01       Impact factor: 23.059

7.  Focal lesions of muscle in peripheral vascular disease.

Authors:  W K Engel; R J Hawley
Journal:  J Neurol       Date:  1977-06-13       Impact factor: 4.849

8.  Muscle blood flow in Duchenne type muscular dystrophy, limb-girdle dystrophy, polymyositis, and in normal controls.

Authors:  O B Paulson; A G Engel; M R Gomez
Journal:  J Neurol Neurosurg Psychiatry       Date:  1974-06       Impact factor: 10.154

Review 9.  Targeting IRES-dependent translation as a novel approach for treating Duchenne muscular dystrophy.

Authors:  Christine Péladeau; Bernard J Jasmin
Journal:  RNA Biol       Date:  2020-11-19       Impact factor: 4.652

Review 10.  Functional muscle ischemia in Duchenne and Becker muscular dystrophy.

Authors:  Gail D Thomas
Journal:  Front Physiol       Date:  2013-12-18       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.